PDE-5 inhibitors in scleroderma raynaud phenomenon and digital ulcers: current status of clinical trials
Systemic sclerosis- (SSc-) related vasculopathy, as manifested by Raynaud's Phenomenon (RP) and digital ulcers (DUs), is associated with significant impairment of the quality of life …..... Read More